Clinical Trial: Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07258147) titled 'Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases' on Nov. 18.

Brief Summary: This is clinical trial evaluating the safety and efficacy of radiotherapy combined with immunotherapy and chemotherapy in patients with extensive-stage small-cell lung cancer (ES-SCLC) and liver metastases.

Study Start Date: Dec. 25

Study Type: INTERVENTIONAL

Condition: Lung Cancer (SCLC)

Intervention: DRUG: Immunotherapy

Combined With Chemotherapy( (Etoposide, Nab-paclitaxel, Irinotecan, or Lurbinectedin) ). Liver-directed radiotherapy (low-dose radiation(3Gy*5d) or low-dose radia...